Senior Director, Head of New Product Strategy and Commercialization

Sarepta TherapeuticsCambridge, MA
$222,400 - $278,000Hybrid

About The Position

The Head of New Product Strategy and Commercialization is responsible for the global commercial strategy of Sarepta's pipeline of best-in-class siRNA assets. This role involves co-leading the program Asset Team with an R&D co-lead, shaping and advancing asset strategy in partnership with cross-functional peers. The individual must be adept at driving timely, high-quality decisions, aligning diverse stakeholders across a complex matrix organization, and being accountable for recommendations and outcomes to executive management. For later-stage assets, this role is accountable for actionable brand strategic and tactical plans to optimize launch readiness and commercial success, including disease awareness communications. The role also partners closely with Business Development to provide commercial assessments of external opportunities and support discussions on potential external partnerships.

Requirements

  • Bachelor’s degree with 15+ years or (MBA preferred with 13+ years) of experience in biotech/pharma strategic roles with a track record demonstrating accountability, sense of urgency and cross functional leadership.
  • Strong commercial acumen with significant experience in commercial strategy, brand marketing, brand strategy, and product management is required.
  • Extensive understanding of drug development and proven track record of using deep customer and market insight to deliver informed recommendations to R&D decisions that ensure attainment of commercial objectives.
  • Excellent organizational skills, sufficient to multi-task in an extremely fast-paced environment with changing priorities.
  • Strong leadership abilities to influence and lead across a matrix environment, drive timely cross-functional decisions, and be accountable for asset-level recommendations and outcomes.
  • Experience in high science, competitive markets required.
  • Experience supporting business development through commercial opportunity assessment and due diligence, including evaluation of external assets, markets, and strategic fit.
  • Candidates must be authorized to work in the U.S.

Nice To Haves

  • Global product launch experience in rare disease is preferred.
  • MBA preferred

Responsibilities

  • Own the asset strategic roadmap and long-term vision, ensuring commercial perspective is embedded in enterprise decision-making.
  • Be accountable for delivery of the asset objectives against corporate goals, including key strategic recommendations, trade-off decisions, and execution milestones.
  • Drive asset-level cross-functional decision-making by integrating functional input, resolving ambiguity, and escalating critical issues when needed.
  • Identify, assess, and elevate asset-level risks and opportunities, with clear ownership of mitigation strategies and decision follow-through.
  • Lead the development of target product profiles for pipeline assets, based on thorough understanding of market dynamics and potential future trends.
  • Partner with Market Access, Medical, and HEOR to build evidence and value strategies that support payer engagement and access for commercialization.
  • Partner with Commercial Operations and Manufacturing to develop integrated forecasts and market potential assessments.
  • Lead commercial assessments of potential therapeutic targets and programs.

Benefits

  • Competitive compensation and benefit package
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service